359 related articles for article (PubMed ID: 11912872)
21. Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas.
Devaprasath A; Chacko G
Neurol India; 2003 Sep; 51(3):336-40. PubMed ID: 14652433
[TBL] [Abstract][Full Text] [Related]
22. The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors.
Vargas MP; Vargas HI; Kleiner DE; Merino MJ
Mod Pathol; 1997 Jan; 10(1):12-7. PubMed ID: 9021722
[TBL] [Abstract][Full Text] [Related]
23. [Report of seven cases of clear-cell meningioma and a literature review].
Rousselot C; Francois P; Jan M; Bergemer AM
Ann Pathol; 2010 Apr; 30(2):73-82. PubMed ID: 20451062
[TBL] [Abstract][Full Text] [Related]
24. Expression of apoptotic and proliferation markers in meningiomas.
Konstantinidou AE; Pavlopoulos PM; Patsouris E; Kaklamanis L; Davaris P
J Pathol; 1998 Nov; 186(3):325-30. PubMed ID: 10211124
[TBL] [Abstract][Full Text] [Related]
25. Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas.
Torp SH; Lindboe CF; Granli US; Moen TM; Nordtømme T
Clin Neuropathol; 2001; 20(5):190-5. PubMed ID: 11594503
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
Suthipintawong C; Wejaranayang C; Vipupinyo C
J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
[TBL] [Abstract][Full Text] [Related]
27. Correlation between MIB-1 staining index and the immunoreactivity of p53 protein in recurrent and non-recurrent meningiomas.
Matsuno A; Nagashima T; Matsuura R; Tanaka H; Hirakawa M; Murakami M; Tamura A; Kirino T
Am J Clin Pathol; 1996 Dec; 106(6):776-81. PubMed ID: 8980354
[TBL] [Abstract][Full Text] [Related]
28. The significance of immunohistochemical expression of Ki-67, p53, p21, and p16 in meningiomas tissue arrays.
Terzi A; Saglam EA; Barak A; Soylemezoglu F
Pathol Res Pract; 2008; 204(5):305-14. PubMed ID: 18374497
[TBL] [Abstract][Full Text] [Related]
29. PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinico-pathologic aspects.
Tuccari G; Rizzo A; Muscarà M; Giuffrè G; Barresi G
Pathologica; 1993; 85(1095):47-55. PubMed ID: 8100059
[TBL] [Abstract][Full Text] [Related]
30. Hormonal dependency of cerebral meningiomas. Part 1: Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy.
Schrell UM; Adams EF; Fahlbusch R; Greb R; Jirikowski G; Prior R; Ramalho-Ortigao FJ
J Neurosurg; 1990 Nov; 73(5):743-9. PubMed ID: 2213164
[TBL] [Abstract][Full Text] [Related]
31. Progesterone and estrogen receptors in meningiomas: prognostic considerations.
Hsu DW; Efird JT; Hedley-Whyte ET
J Neurosurg; 1997 Jan; 86(1):113-20. PubMed ID: 8988089
[TBL] [Abstract][Full Text] [Related]
32. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
Ferrandina G; Ranelletti FO; Gallotta V; Martinelli E; Zannoni GF; Gessi M; Scambia G
Gynecol Oncol; 2005 Sep; 98(3):383-9. PubMed ID: 15979129
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of progesterone receptor status in meningiomas.
Roser F; Nakamura M; Bellinzona M; Rosahl SK; Ostertag H; Samii M
J Clin Pathol; 2004 Oct; 57(10):1033-7. PubMed ID: 15452155
[TBL] [Abstract][Full Text] [Related]
34. Expression of the proliferating cell nuclear antigen and clinicopathological features in intracranial meningiomas.
Kim CH; Cheong JH; Bak KH; Kim JM; Oh SJ
J Clin Neurosci; 2001 May; 8 Suppl 1():44-8. PubMed ID: 11386825
[TBL] [Abstract][Full Text] [Related]
35. Proliferation and progesterone receptor status in benign meningiomas are not age dependent.
Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS
Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas.
Takei H; Buckleair LW; Powell SZ
Neuropathology; 2008 Feb; 28(1):62-8. PubMed ID: 18021195
[TBL] [Abstract][Full Text] [Related]
37. Secondary intracranial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature.
Strojan P; Popović M; Jereb B
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):65-73. PubMed ID: 10924973
[TBL] [Abstract][Full Text] [Related]
38. Immunoreactive estrogen receptor protein in meningiomas: comparison with the androgen receptor and progesterone receptor binding activity.
Lesch KP; Engl HG; Schott W; Gross S
Zentralbl Neurochir; 1987; 48(2):124-34. PubMed ID: 3314266
[TBL] [Abstract][Full Text] [Related]
39. [Expression of steroid receptors and DNA synthesis in male breast cancer].
Petroni S; Mangia A; D'Amico C; Simone G
Pathologica; 2003 Feb; 95(1):31-6. PubMed ID: 12735283
[TBL] [Abstract][Full Text] [Related]
40. Effects of short-term tamoxifen administration in patients with invasive cervical carcinoma.
Vargas Roig LM; Lotfi H; Olcese JE; Lo Castro G; Ciocca DR
Anticancer Res; 1993; 13(6B):2457-63. PubMed ID: 7907850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]